by mapolzan@aihep.org | Oct 10, 2024 | Autoimmune Hepatitis Education
How Socioeconomic Status Impacts Autoimmune Hepatitis By Craig Lammert, M.D., AIHA Executive Director Quality of Life Differences in AIH Over the past decade, researchers have shown that people with autoimmune hepatitis (AIH) often face a lower quality of life. This...
by admin | Jan 30, 2024 | Autoimmune Hepatitis Education
Azathioprine Alternatives for Autoimmune Hepatitis By Craig Lammert, M.D., AIHA Executive Director Azathioprine (Imuran) has reigned as the most common medication to treat autoimmune hepatitis (AIH) beyond steroids for more than 50 years. Yet, over the years, patients...
by admin | Jun 30, 2023 | Autoimmune Hepatitis Education, Pediatric
Type 1 and Type 2 Autoimmune Hepatitis: Key Similarities By Craig Lammert, M.D., AIHA Executive Director Doctors have long recognized two types of autoimmune hepatitis (AIH): Type 1 and Type 2. Type 2 AIH, marked by the antibodies anti-LKM1 or LC1, appears more common...
by admin | May 17, 2023 | Autoimmune Hepatitis Education
How the Bubonic Plague Shaped Autoimmune Diseases By Craig Lammert, M.D. AIHA Executive Director The Black Death and Its Unexpected Legacy The bubonic plague often brings to mind flea bites and swollen lymph nodes. However, should we also connect the Black Death with...
by admin | May 13, 2023 | Autoimmune Hepatitis Education
The Autoimmune Hepatitis Association The treatment for autoimmune hepatitis (AIH) hasn’t changed much in the past 60 years; however, a newer steroid called budesonide has been increasingly used since it may have fewer steroid side effects compared to prednisone....
by admin | Oct 11, 2022 | Autoimmune Hepatitis Education
The Autoimmune Hepatitis Association Research studies have long suggested that patients with autoimmune diseases may be at higher risk of cardiovascular disease such as heart attacks and stroke. Concerningly, most doctors and patients are unaware of this association....
Recent Comments